We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

16 hedge funds and large institutions have $4.44M invested in ImmuCell in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

15.4% more ownership

Funds ownership: 0% → 15.4% (+15%)

16% less funds holding

Funds holding: 19 → 16 (-3)

34% less capital invested

Capital invested by funds: $6.69M → $4.44M (-$2.25M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$140K
2
PCM
Perritt Capital Management
Illinois
+$106K
3
Renaissance Technologies
Renaissance Technologies
New York
+$78.5K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$75.7K
5
Deutsche Bank
Deutsche Bank
Germany
+$41.3K

Top Sellers

Rank Fund Capital Flow
1
NC
Northpointe Capital
Michigan
-$1.39M
2
Morgan Stanley
Morgan Stanley
New York
-$62.7K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$15K
4
TRCT
Tower Research Capital (TRC)
New York
-$4K
5
Bank of America
Bank of America
North Carolina
-$1.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.34M – – –
HP
2
HealthInvest Partners
Sweden
$1M – – –
PCM
3
Perritt Capital Management
Illinois
$595K +$106K +17,371 +21%
Renaissance Technologies
4
Renaissance Technologies
New York
$513K +$78.5K +12,900 +18%
SRC
5
Shufro Rose & Co
New York
$263K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$203K +$75.7K +12,433 +57%
Wells Fargo
7
Wells Fargo
California
$143K +$140K +23,000 +2,298%
EFS
8
Essex Financial Services
Connecticut
$141K – – –
MA
9
Minerva Advisors
Pennsylvania
$85K – – –
Deutsche Bank
10
Deutsche Bank
Germany
$61K +$41.3K +6,778 +189%
Morgan Stanley
11
Morgan Stanley
New York
$44K -$62.7K -10,305 -58%
UBS Group
12
UBS Group
Switzerland
$34K +$8.68K +1,426 +33%
Bank of America
13
Bank of America
North Carolina
$12K -$1.3K -213 -9%
BFA
14
BlackRock Fund Advisors
California
$4K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$3K – – –
NC
16
Northpointe Capital
Michigan
– -$1.39M -179,260 Closed
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
– -$15K -1,923 Closed
TRCT
18
Tower Research Capital (TRC)
New York
– -$4K -551 Closed

ICCC Hedge Fund Activity: Q4 2016 in Review

16 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2016, worth a combined $4.44M — down 34% from $6.69M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ICCC and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 6 added.

The largest buyer was Wells Fargo, adding an estimated $140K. The largest seller was Northpointe Capital, exiting entirely with an estimated $1.39M sold.

  • 16 institutional investors held ImmuCell (ICCC) as of Q4 2016, down from 19 in Q3 2016.
  • Funds reported $4.44M of ImmuCell stock for Q4 2016, down 34% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q4 2016 and 3 closed out, a net change of -3 holders.
  • The largest ImmuCell buyer in Q4 2016 was Wells Fargo, an estimated $140K added.
  • The largest ImmuCell seller in Q4 2016 was Northpointe Capital, an estimated $1.39M sold.

Based on aggregated 13F filings for Q4 2016.